Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).
Lamonica, D
Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). [electronic resource] - Cancer biotherapy & radiopharmaceuticals Dec 2002 - 689-97 p. digital
Publication Type: Comparative Study; Journal Article
1084-9785
10.1089/108497802320970307 doi
Antibodies, Monoclonal
Humans
Lymphoma, B-Cell--diagnostic imaging
Magnetic Resonance Imaging
Radioimmunodetection
Recurrence
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed
Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL). [electronic resource] - Cancer biotherapy & radiopharmaceuticals Dec 2002 - 689-97 p. digital
Publication Type: Comparative Study; Journal Article
1084-9785
10.1089/108497802320970307 doi
Antibodies, Monoclonal
Humans
Lymphoma, B-Cell--diagnostic imaging
Magnetic Resonance Imaging
Radioimmunodetection
Recurrence
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed